Ryan Nicholson Sells 357 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) CAO Ryan Nicholson sold 357 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $60.63, for a total value of $21,644.91. Following the transaction, the chief accounting officer owned 36,984 shares of the company’s stock, valued at $2,242,339.92. This represents a 0.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Dolby Laboratories Trading Up 1.3%

DLB stock opened at $61.70 on Friday. The firm has a market capitalization of $5.78 billion, a PE ratio of 26.26 and a beta of 0.80. Dolby Laboratories has a 1-year low of $48.26 and a 1-year high of $75.66. The business’s 50 day simple moving average is $52.82 and its 200 day simple moving average is $58.49.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.67 by $0.02. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%.The business had revenue of $305.00 million during the quarter, compared to the consensus estimate of $311.96 million. During the same quarter last year, the firm posted $0.78 EPS. The company’s quarterly revenue was down 3.3% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, sell-side analysts predict that Dolby Laboratories will post 3.21 EPS for the current fiscal year.

Dolby Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th will be paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Tuesday, August 11th. Dolby Laboratories’s dividend payout ratio (DPR) is currently 61.28%.

Dolby Laboratories announced that its board has initiated a share repurchase program on Thursday, July 30th that authorizes the company to buyback $350.00 million in shares. This buyback authorization authorizes the electronics maker to reacquire up to 7% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board believes its stock is undervalued.

Analyst Ratings Changes

A number of brokerages recently commented on DLB. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Wednesday, June 24th. Rosenblatt Securities restated a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a report on Friday, July 31st. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $90.00 target price on shares of Dolby Laboratories in a research report on Monday, June 15th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $90.75.

Institutional Trading of Dolby Laboratories

Several large investors have recently modified their holdings of DLB. Bank of New York Mellon Corp acquired a new position in Dolby Laboratories in the second quarter valued at about $253,289,000. State Street Corp grew its stake in Dolby Laboratories by 8.7% during the second quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock worth $167,906,000 after buying an additional 180,072 shares in the last quarter. First Trust Advisors LP increased its holdings in Dolby Laboratories by 19.9% in the 1st quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock valued at $135,431,000 after buying an additional 374,405 shares during the period. Geode Capital Management LLC increased its holdings in Dolby Laboratories by 15.6% in the 4th quarter. Geode Capital Management LLC now owns 1,885,246 shares of the electronics maker’s stock valued at $122,749,000 after buying an additional 254,250 shares during the period. Finally, AQR Capital Management LLC raised its position in shares of Dolby Laboratories by 51.8% in the 2nd quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after buying an additional 592,282 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.